Trial intelligence / Profile preview

Gastric Emptying and Insulin Bolus Strategies in Type 1 Diabetes

NCT02365740Unknown

Sponsor
University of Naples Federico II
Start
Nov 2014
Primary completion
Nov 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label trial of human insulin in type 1 diabetes mellitus (T1D) (2 arms), sponsored by University of Naples Federico II. Primary endpoint: Gastric Emptying Measure (t1/2 and tlag) at 4 hours. Status: unknown.

02

Drugs

human insulin
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT02365740.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02365740.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call